Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
NCT00005012
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Peginterferon alfa-2b
Sponsor
Schering-Plough